TGFB1 and neoplasm: Most importantly, since each tumor type utilizes TGFβ signaling to drive a different aspect of tumor progression, a major challenge is to identify the overriding cellular targets and molecular mechanisms that drive TGFβ blockade responses for each tumor class.